EMJ Podcast: Latest Developments in RET-driven lung cancer - European Medical Journal

EMJ Podcast: Latest Developments in RET-driven lung cancer

Bonus Episode

Latest Developments in RET-driven lung cancer

This podcast, supported by an educational grant from Eli Lilly, explores the latest developments in RET‑driven lung cancer that were presented at the American Society of Clinical Oncology’s (ASCO) 2021 virtual conference. Hear from two experts, Dr Maximilian Hochmair and Dr Fernando Lopez-Rios, as they discuss the importance of the RET gene, the latest safety and efficacy information, the role of testing, and future predictions within this landscape.

Spotify | Apple | Download MP3 (mp 33:46 mins)

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given